🔴 Alvotech is trading 3.12% down today amid risk-off sentiment ahead of Tuesday’s Fed decision

Alvotech is trading 3.12% down at ISK 622 as the broader market turns risk-off ahead of Tuesday’s Federal Reserve decision.

• Technology weakness, higher oil prices, and geopolitical supply concerns are pressuring equities.
• No fresh September 14 company-specific announcement was identified.
• A September 1 Takeda patent lawsuit involving Alvotech’s AVT16 biosimilar remains relevant background, but available coverage does not directly link it to the September 14 decline.